As of May 23, 2025, Cnova NV's estimated intrinsic value ranges from $7.53 to $7.53 per share, depending on the valuation methodology applied.
Valuation Method | Fair Value (USD) | Implied Upside/Downside |
---|---|---|
Earnings Power Value | $7.53 | +7978.8% |
Is Cnova NV (CNV.PA) undervalued or overvalued?
With the current market price at $0.09, the stock appears to be significantly undervalued.
Intrinsic value represents the "true" worth of a company based on its fundamentals rather than market sentiment. We've employed multiple methodologies to triangulate Cnova NV's intrinsic value, including:
The cost of capital is a critical factor in valuation models, representing the required return for investors.
WACC Component | Low | High |
---|---|---|
Long-term bond rate | 3.0% | 3.5% |
Equity market risk premium | 5.8% | 6.8% |
Adjusted beta | 7.82 | 13.08 |
Cost of equity | 48.5% | 93.2% |
Cost of debt | 4.0% | 9.1% |
Tax rate | 7.8% | 13.6% |
Debt/Equity ratio | 24.7 | 24.7 |
After-tax WACC | 5.4% | 11.2% |
EPV assesses a company's value based on its current normalized earnings power, assuming no growth.
EPV Component | Value |
---|---|
Normalized Earnings | $249M |
Discount Rate (WACC) | 11.2% - 5.4% |
Enterprise Value | $2,223M - $4,590M |
Net Debt | $807M |
Equity Value | $1,416M - $3,782M |
Outstanding Shares | 345M |
Fair Value | $4 - $11 |
Selected Fair Value | $7.53 |
Metric | Value |
---|---|
Market Capitalization | $32M |
Enterprise Value | $839M |
Trailing P/E | 0.00 |
Forward P/E | 0.00 |
Trailing EV/EBITDA | 3.00 |
Current Dividend Yield | 0.00% |
Dividend Growth Rate (5Y) | 0.00% |
Debt-to-Equity Ratio | 24.70 |
To determine the most reliable intrinsic value estimate, we weigh each valuation method based on:
Valuation Method | Weight | Weighted Value |
---|---|---|
Earnings Power Value | 100% | $0.75 |
Weighted Average | 100% | $7.53 |
Based on our comprehensive valuation analysis, Cnova NV's weighted average intrinsic value is $7.53, which is approximately 7978.8% above the current market price of $0.09.
Key investment considerations:
Given these factors, we believe Cnova NV is currently significantly undervalued with the potential for long-term appreciation based on the company's growth trajectory and financial strength.